2000
International Implications of 35 U.S.C. Sec. 271(e)(1), the “Safe Harbor” Provision of the Drug Price Competition and Patent Term Restoration Act of 1984 (Hatch/Waxman Act), American Chemical Society Annual Meeting
This event has already occurred.
Related Insights
EYLEA® Proposed Biosimilar M710 BPCIA Appeals Dismissed for Lack of Jurisdiction
EYLEA® Proposed Biosimilar M710 BPCIA Appeals Dismissed for Lack of Jurisdiction
April 17, 2024
2min
Not So Fast: FTC Letter Rebukes Direct Selling Self-Regulatory Council Guidance
Not So Fast: FTC Letter Rebukes Direct Selling Self-Regulatory Council Guidance
April 17, 2024
3min
SCOTUS Rules for Landowner in Fifth Amendment Takings Clause Case
SCOTUS Rules for Landowner in Fifth Amendment Takings Clause Case
April 17, 2024
4min
Events
AI in Pharma: Transforming Life Sciences IP and Reshaping the Hatch-Waxman Litigation Landscape
AI in Pharma: Transforming Life Sciences IP and Reshaping the Hatch-Waxman Litigation Landscape
April 25 - 26, 2024 New York, NY - American Conference Institute
Potential Advertising Pitfalls for Consumer Financial Product and Service Providers
Potential Advertising Pitfalls for Consumer Financial Product and Service Providers
April 25, 2024 Washington, DC - Venable
Consumer Financial Services Legal and Regulatory Update at the FCAA 2024 Annual Conference
Consumer Financial Services Legal and Regulatory Update at the FCAA 2024 Annual Conference
May 01 - 03, 2024 New Orleans, LA - Financial Counseling Association of America (FCAA)